HMGB1 increases permeability of the endothelial cell monolayer via RAGE and Src family tyrosine kinase pathways

Inflammation

Volumn 35, Issue 1, 2012, Pages 350-362

  Huang, Wenchang ^a   Liu, Yiyun ^a   Li, Lei ^a   Zhang, Ruyuan ^a   Liu, Wei ^a   Wu, Jun ^a   Mao, Enqiang ^a   Tang, Yaoqing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

HMGB1; Permeability; RAGE; Sepsis; SiRNA

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; HIGH MOBILITY GROUP B1 PROTEIN; MESSENGER RNA; PROTEIN TYROSINE KINASE; VASCULAR ENDOTHELIAL CADHERIN;

ADVANCED GLYCATION END PRODUCT RECEPTOR GENE; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ASSAY; CELL MEMBRANE PERMEABILITY; CELL SURFACE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; MEDIATOR RELEASE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR BLOCKING; RECEPTOR GENE; SEPSIS; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, NEOPLASM; APOPTOSIS; CAPILLARY PERMEABILITY; CELLS, CULTURED; ENDOTHELIAL CELLS; HMGB1 PROTEIN; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASES; PERMEABILITY; PYRIMIDINES; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84859420581     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-011-9325-5     Document Type: Article

References (55)

1. Cross, A.S., and S.M. Opal. 2003. A new paradigm for the treatment of sepsis: is it time to consider combination therapy? Annals of Internal Medicine 138(6): 502-505. (Pubitemid 38129029)
2. Opal, S.M. 2007. The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis. International Journal of Medical Microbiology 297(5): 365-377. (Pubitemid 47188050)
3. Martin, G.S., D.M. Mannino, S. Eaton, and M. Moss. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. The New England Journal of Medicine 348(16): 1546-1554. (Pubitemid 36437931)
4. Wenzel, R.P. 2002. Treating sepsis. The New England Journal of Medicine 347(13): 966-967.
5. Brun-Buisson, C., F. Doyon, J. Carlet, P. Dellamonica, F. Gouin, A. Lepoutre, J.C. Mercier, G. Offenstadt, and B. Régnier. 1995. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 274(12): 968-974.
6. Legrand, M., E. Klijn, D. Payen, and C. Ince. 2010. The response of the host microcirculation to bacterial sepsis: Does the pathogen matter? Journal of Molecular Medicine 88(2): 127-133.
7. Martin, M.A., and H.J. Silverman. 1992. Gram-negative sepsis and the adult respiratory distress syndrome. Clinical Infectious Diseases 14: 1213-1228.
8. Parsons, P.E., G.S. Worthen, E.E. Moore, R.M. Tate, and P.M. Henson. 1989. The association of circulating endotoxin with the development of the adult respiratory distress syndrome. The American Review of Respiratory Disease 140: 294-301. (Pubitemid 19218338)
9. Hudson, L.D., J.A. Milberg, D. Anardi, and R.J. Maunder. 1995. Clinical risks for development of the acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 151(2 Pt 1): 293-301.
10. Tracey, K.J., B. Beutler, S.F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, R.J. Hariri, T.J. Fahey 3rd, A. Zentella, J.D. Albert, et al. 1986. Shock and tissue injury induced by recombinant human cachectin. Science 234(4775): 470-474. (Pubitemid 17181429)
11. Wang, H., O. Bloom, M. Zhang, J.M. Vishnubhakat, M. Ombrellino, J. Che, A. Frazier, H. Yang, S. Ivanova, L. Borovikova, K.R. Manogue, E. Faist, E. Abraham, J. Andersson, U. Andersson, P.E. Molina, N.N. Abumrad, A. Sama, and K.J. Tracey. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285(5425): 248-251. (Pubitemid 29329996)
12. Mark, K.S., and D.W. Miller. 1999. Increased permeability of primary cultured brain microvessel endothelial cell monolayers following TNF-alpha exposure. Life Sciences 64(21): 1941-1953. (Pubitemid 29215195)
13. Marano, C.W., S.A. Lewis, L.A. Garulacan, A.P. Soler, and J.M. Mullin. 1998. Tumor necrosis factor-alpha increases sodium and chloride conductance across the tight junction of CACO-2 BBE, a human intestinal epithelial cell line. The Journal of Membrane Biology 161(3): 263-274. (Pubitemid 28085051)
14. Hybertson, B.M., E.K. Jepson, O.J. Cho, J.H. Clarke, Y.M. Lee, and J.E. Repine. 1997. TNF mediates lung leak, but not neutrophil accumulation, in lungs of rats given IL-1 intratracheally. American Journal of Respiratory and Critical Care Medicine 155(6): 1972-1976. (Pubitemid 27256127)
15. Saulpaw, C.E., and W.L. Joyner. 1997. Bradykinin and tumor necrosis factor-alpha alter albumin transport in vivo: a comparative study. Microvascular Research 54(3): 221-232. (Pubitemid 28066514)
16. Sundén-Cullberg, J., A. Norrby-Teglund, A. Rouhiainen, H. Rauvala, G. Herman, K.J. Tracey, M.L. Lee, J. Andersson, L. Tokics, and C.J. Treutiger. 2005. Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Critical Care Medicine 33(3): 564-573. (Pubitemid 40365558)
17. Abraham, E., J. Arcaroli, A. Carmody, H. Wang, and K.J. Tracey. 2000. HMG-1 as a mediator of acute lung inflammation. Journal of Immunology 165(6): 2950-2954.
18. Fiuza, C., M. Bustin, S. Talwar, M. Tropea, E. Gerstenberger, J.H. Shelhamer, and A.F. Suffredini. 2003. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 101(7): 2652-2660. (Pubitemid 36857626)
19. Lal, B.K., S. Varma, P.J. Pappas, R.W. Hobson 2nd, and W.N. Durán. 2001. VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways. Microvascular Research 62 (3): 252-262. (Pubitemid 33027911)
20. Breslin, J.W., P.J. Pappas, J.J. Cerveira, R.W. Hobson 2nd, and W. N. Durán. 2003. VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. American Journal of Physiology. Heart and Circulatory Physiology 284(1): H92-H100. (Pubitemid 36076274)
21. Yang, X., D.A. Fullerton, X. Su, L. Ao, J.C. Cleveland Jr., and X. Meng. 2009. Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of Toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2. Journal of the American College of Cardiology 53(6): 491-500.
22. Su X, Ao L, Shi Y, Johnson TR, Fullerton DA, Meng X. 2011. Oxidized low-density lipoprotein induces bone morphogenetic protein-2 in coronary artery endothelial cells via Toll-like receptors 2 and 4. Journal of Biological Chemistry 286(14): 12213-12220.
23. Huttunen, H.J., and H. Rauvala. 2004. Amphoterin as an extracellular regulator of cell motility: From discovery to disease. Journal of Internal Medicine 255(3): 351-366. (Pubitemid 38315276)
24. Czura, C.J., H. Wang, and K.J. Tracey. 2001. Dual roles for HMGB1: DNA binding and cytokine. Journal of Endotoxin Research 7(4): 315-321. (Pubitemid 33041072)
25. Andersson, U., H. Wang, K. Palmblad, A.C. Aveberger, O. Bloom, H. Erlandsson-Harris, A. Janson, R. Kokkola, M. Zhang, and H. Yang. 2000. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. The Journal of Experimental Medicine 192(4): 565-570. (Pubitemid 30666257)
26. Wang, H., S. Zhu, R. Zhou, W. Li, and A.E. Sama. 2008. Therapeutic potential of HMGB1-targeting agents in sepsis. Expert Reviews in Molecular Medicine 10: e32.
27. Andriopoulou, P., P. Navarro, A. Zanetti, M.G. Lampugnani, and E. Dejana. 1999. Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions. Arteriosclerosis, Thrombosis, and Vascular Biology 19(10): 2286-2297. (Pubitemid 29477828)
28. Collares-Buzato, C.B., M.A. Jepson, N.L. Simmons, and B.H. Hirst. 1998. Increased tyrosine phosphorylation causes redistribution of adherens junction and tight junction proteins and perturbs paracellular barrier function in MDCK epithelia. European Journal of Cell Biology 76(2): 85-92. (Pubitemid 28312630)
29. Konstantoulaki, M., P. Kouklis, and A.B. Malik. 2003. Protein kinase C modifications of VE-cadherin, p120, and beta-catenin contribute to endothelial barrier dysregulation induced by thrombin. American Journal of Physiology. Lung Cellular and Molecular Physiology 285(2): L434-L442. (Pubitemid 36909460)
30. Harris, E.S., and W.J. Nelson. 2010. VE-cadherin: At the front, center, and sides of endothelial cell organization and function. Current Opinion in Cell Biology 22(5): 651-658.
31. Gulino, D., E. Delachanal, E. Concord, Y. Genoux, B. Morand, M. O. Valiron, E. Sulpice, R. Scaife, M. Alemany, and T. Vernet. 1998. Alteration of endothelial cell monolayer integrity triggers resynthesis of vascular endothelium cadherin. The Journal of Biological Chemistry 273(45): 29786-29793. (Pubitemid 28509991)
32. Rabiet, M.J., J.L. Plantier, Y. Rival, Y. Genoux, M.G. Lampugnani, and E. Dejana. 1996. Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization. Arteriosclerosis, Thrombosis, and Vascular Biology 16(3): 488-496. (Pubitemid 26084325)
33. Alexander, J.S., B.C. Alexander, L.A. Eppihimer, N. Goodyear, R. Haque, C.P. Davis, T.J. Kalogeris, D.L. Carden, Y.N. Zhu, and C. G. Kevil. 2000. Inflammatory mediators induce sequestration of VE-cadherin in cultured human endothelial cells. Inflammation 24 (2): 99-113. (Pubitemid 30127816)
34. Tabibzadeh, S., Q.F. Kong, S. Kapur, P.G. Satyaswaroop, and K. Aktories. 1995. Tumour necrosis factor-alpha-mediated dyscohesion of epithelial cells is associated with disordered expression of cadherin/beta-catenin and disassembly of actin filaments. Human Reproduction 10(4): 994-1004.
35. Alexander, J.S., S.A. Jackson, E. Chaney, C.G. Kevil, and F.R. Haselton. 1998. The role of cadherin endocytosis in endothelial barrier regulation: Involvement of protein kinase C and actin-cadherin interactions. Inflammation 22(4): 419-433. (Pubitemid 28376857)
36. Kevil, C.G., N. Ohno, D.C. Gute, N. Okayama, S.A. Robinson, E. Chaney, and J.S. Alexander. 1998. Role of cadherin internalization in hydrogen peroxide-mediated endothelial permeability. Free Radical Biology & Medicine 24(6): 1015-1022. (Pubitemid 28186243)
37. Nwariaku, F.E., J. Chang, X. Zhu, Z. Liu, S.L. Duffy, N.H. Halaihel, L. Terada, and R.H. Turnage. 2002. The role of p38 map kinase in tumor necrosis factor-induced redistribution of vascular endothelial cadherin and increased endothelial permeability. Shock 18(1): 82-85.
38. Wong, R.K., A.L. Baldwin, and R.L. Heimark. 1999. Cadherin-5 redistribution at sites of TNF-alpha and IFN-gamma-induced permeability in mesenteric venules. The American Journal of Physiology 276(2 Pt 2): H736-H748. (Pubitemid 29100644)
39. Schlegel, N., Y. Baumer, D. Drenckhahn, and J. Waschke. 2009. Lipopolysaccharide-induced endothelial barrier breakdown is cyclic adenosine monophosphate dependent in vivo and in vitro. Critical Care Medicine 37(5): 1735-1743.
40. Park, J.S., F. Gamboni-Robertson, Q. He, D. Svetkauskaite, J. Y. Kim, D. Strassheim, J.W. Sohn, S. Yamada, I. Maruyama, A. Banerjee, A. Ishizaka, and E. Abraham. 2006. High mobility group box 1 protein interacts with multiple Toll-like receptors. American Journal of Physiology. Cell Physiology 290(3): C917-C924.
41. Kokkola, R., A. Andersson, G. Mullins, T. Ostberg, C.J. Treutiger, B. Arnold, P. Nawroth, U. Andersson, R.A. Harris, and H.E. Harris. 2005. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scandinavian Journal of Immunology 61(1): 1-9. (Pubitemid 40188342)
42. Rouhiainen, A., J. Kuja-Panula, E. Wilkman, J. Pakkanen, J. Stenfors, R.K. Tuominen, M. Lepäntalo, O. Carpén, and J. Parkkinen. 2004. Regulation of monocyte migration by amphoterin (HMGB1). Blood 104(4): 1174-1182. (Pubitemid 39038040)
43. Treutiger, C.J., G.E. Mullins, A.S. Johansson, A. Rouhiainen, H. M. Rauvala, H. Erlandsson-Harris, U. Andersson, H. Yang, K.J. Tracey, J. Andersson, and J.E. Palmblad. 2003. High mobility group 1 B-box mediates activation of human endothelium. Journal of Internal Medicine 254(4): 375-385. (Pubitemid 37211261)
44. Hori, O., J. Brett, T. Slattery, R. Cao, J. Zhang, J.X. Chen, M. Nagashima, E.R. Lundh, S. Vijay, D. Nitecki, et al. 1995. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. The Journal of Biological Chemistry 270(43): 25752-25761.
45. Huang, W., Y. Tang, and L. Li. 2010. HMGB1, a potent proinflammatory cytokine in sepsis. Cytokine 51: 119-126.
46. Huttunen, H.J., C. Fages, J. Kuja-Panula, A.J. Ridley, and H. Rauvala. 2002. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Research 62(16): 4805-4811.
47. Huttunen, H.J., C. Fages, and H. Rauvala. 1999. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. The Journal of Biological Chemistry 274(28): 19919-19924.
48. Park, J.S., D. Svetkauskaite, Q. He, J.Y. Kim, D. Strassheim, A. Ishizaka, and E. Abraham. 2004. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. The Journal of Biological Chemistry 279(9): 7370-7377. (Pubitemid 38294612)
49. Lv, B., H. Wang, Y. Tang, Z. Fan, X. Xiao, and F. Chen. 2009. High-mobility group box 1 protein induces tissue factor expression in vascular endothelial cells via activation of NF-kappaB and Egr-1. Thrombosis and Haemostasis 102(2): 352-359.
50. Luan, Z.G., H. Zhang, P.T. Yang, X.C. Ma, C. Zhang, and R.X. Guo. 2010. HMGB1 activates nuclear factor-κB signaling by RAGE and increases the production of TNF-κ in human umbilical vein endothelial cells. Immunobiology 215(12): 956-962.
51. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annual Review of Immunology 21: 335-376. (Pubitemid 37174535)
52. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11(4): 443-451. (Pubitemid 29504199)
53. Aderem, A., and R.J. Ulevitch. 2000. Toll-like receptors in the induction of the innate immune response. Nature 406(6797): 782-787.
54. Poltorak, A., X. He, I. Smirnova, M.Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, M. Freudenberg, P. Ricciardi-Castagnoli, B. Layton, and B. Beutler. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282(5396): 2085-2088. (Pubitemid 29001265)
55. Aleshin, A., and R.S. Finn. 2010. SRC: a century of science brought to the clinic. Neoplasia 12(8): 599-607.